Eli Lilly has announced it will increase investment to nearly $1 billion at its new biologics drug substance manufacturing facility in Limerick in the Mid West region. The company previously announced a $500 million investment.
Construction of the new 500,000 sq. ft. facility is currently underway at IDA’s Business Park in Raheen and is expected to create more than 300 highly skilled jobs across areas including engineering, scientists, and operations.
The American pharmaceutical company says the new facility will utilise the latest biologics manufacturing technology to produce biologic active ingredients for life changing treatments for patients around the world.
Once the site is operational, the company’s total investment in the site will be approximately $1 billion.
Eli Lilly first established in Ireland in 1978 and currently employs more than 2,700 people in Cork where it has a large manufacturing campus in Kinsale as well as a Global Business Solutions Centre in Little Island.
Welcoming the news, Minister for Enterprise, Trade and Employment, Simon Coveney said, "I am delighted to hear the announcement that Eli Lilly is to increase its investment to nearly $1 billion at its new biologics drug substance manufacturing facility in Raheen Business Park in Limerick."
He added, "The news demonstrates their commitment to Ireland and highlights the wealth of talent we have to offer."
Source: www.businessworld.ie